Bacterin International Holdings, Inc. (NYSE: BONE ), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces that the first clinical results using the OsteoSponge^® product for foot and ankle arthrodesis have been published in The Journal of Foot & Ankle Surgery. The article reports a